Business
AstraZeneca eyes Bristol Myers merger for $400B U.S. scale
0 0
AstraZeneca reportedly held preliminary merger talks with U.S. rival Bristol Myers Squibb, according to reports from the Financial Times and Reuters on August 6, 2026. CNBC has not independently confirmed the discussions, and a senior source later denied the talks to Reuters.
Sources
- CNBC Top NewsSecondary
Related
Chevron and Williams bet big on data center gas plants
SoftBank beats profit forecasts with $2.2 billion net income
Shipowners warn Strait of Hormuz tolls would harm global livelihoods
SpaceX stock plunges 13.6% after first quarterly report
Uber forecasts Q3 bookings of $59.25 billion, below estimates
Eli Lilly raises 2026 revenue outlook to $87B on Mounjaro, Zepbound
Novo Nordisk guidance hike fails to ease obesity business concerns
RBI holds rates at 5.25% as inflation hits 18-month high
Trending now
- Nintendo Direct for Fire Emblem: Fortune's Weave starts at 10AM ET
- SpaceX reports $541m loss but beats expectations
- RBI holds rates at 5.25% as inflation hits 18-month high
- NASA Moon Base landers set for 2028 delivery by Blue Origin, others
- Big Oil posts record profits as Iran war disrupts Hormuz
- Apple alleges more ex-employees took trade secrets to OpenAI
- Bending Spoons buys Airtable for $1.28 billion
- Mistral raises $2B at $13.5B valuation as Europe seeks AI sovereignty
Comments
No comments yet. Be the first.